These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1092768)

  • 41. Properties of a Salmonella typhimurium mutant with an incomplete deficiency of uridinediphosphogalactose-4-epimerase.
    Krishnapillai V; MacPhee DG; Stocker BA
    J Bacteriol; 1971 Jul; 107(1):155-61. PubMed ID: 4935317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen.
    Seid RC; Kopecko DJ; Sadoff JC; Schneider H; Baron LS; Formal SB
    J Biol Chem; 1984 Jul; 259(14):9028-34. PubMed ID: 6378905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
    Wang JY; Pasetti MF; Noriega FR; Anderson RJ; Wasserman SS; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2001 Aug; 69(8):4734-41. PubMed ID: 11447145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of RapidChek® SELECT™ Salmonella to detect shedding of live attenuated Salmonella enterica serovar Typhi vaccine strains.
    Brenneman KE; McDonald C; Kelly-Aehle SM; Roland KL; Curtiss R
    J Microbiol Methods; 2012 May; 89(2):137-47. PubMed ID: 22425882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella typhi Ty2.
    Wahdan MH; Sippel JE; Mikhail IA; Rahka AE; Anderson ES; Sparks HA; Cvjetanović B
    Bull World Health Organ; 1975; 52(1):69-73. PubMed ID: 1082383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Live oral TY 21a--typhoid vaccine.
    Bhatia RS
    J Assoc Physicians India; 1993 Nov; 41(11):770, 773. PubMed ID: 8005959
    [No Abstract]   [Full Text] [Related]  

  • 48. Overexpression of human UDP-glucose pyrophosphorylase rescues galactose-1-phosphate uridyltransferase-deficient yeast.
    Lai K; Elsas LJ
    Biochem Biophys Res Commun; 2000 May; 271(2):392-400. PubMed ID: 10799308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuated typhoid vaccine Salmonella typhi Ty21a: fingerprinting and quality control.
    McKenna AJ; Bygraves JA; Maiden MCJ; Feavers IM
    Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():1993-2002. PubMed ID: 7551062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast.
    Ross KL; Davis CN; Fridovich-Keil JL
    Mol Genet Metab; 2004; 83(1-2):103-16. PubMed ID: 15464425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel method to generate Salmonella Typhi Ty21a ghosts exploiting the λ phage holin-endolysin system.
    Won G; Kim B; Lee JH
    Oncotarget; 2017 Jul; 8(29):48186-48195. PubMed ID: 28637001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled field trial with dried sorbed paratyphoid B and typhoid vaccines.
    Hejfec LB; Levina LA; Kuz'minova ML; Slavina AM; Levites NE; Abidov AZ; Goncarova LF
    Bull World Health Organ; 1971; 45(6):787-94. PubMed ID: 5004428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inactivated Saccharomyces cerevisiae as virulence-enhancing agent in the toxicity test of Salmonella typhi and the immunity assay of typhoid vaccine in mice.
    Lu CH; Chang SN; Tsai MY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):37-45. PubMed ID: 3297534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precautions with oral live typhoid (Ty 21a) vaccine.
    Wolfe MS
    Lancet; 1990 Sep; 336(8715):631-2. PubMed ID: 1975401
    [No Abstract]   [Full Text] [Related]  

  • 55. Uridinediphosphogalactose-4-epimerase deficiency in Salmonella typhimurium and its correction by plasmoid-borne galactose genes of Escherichia coli K-12: effects on mouse virulence, phagocytosis, and serum sensitivity.
    Krishnapillai V
    Infect Immun; 1971 Sep; 4(3):177-88. PubMed ID: 4949486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans.
    Hone DM; Attridge SR; Forrest B; Morona R; Daniels D; LaBrooy JT; Bartholomeusz RC; Shearman DJ; Hackett J
    Infect Immun; 1988 May; 56(5):1326-33. PubMed ID: 3356467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failures with oral typhoid vaccine Ty 21a.
    Hirschel B
    Lancet; 1983 Apr; 1(8328):817-8. PubMed ID: 6132148
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experimental basis for development of a live typhoid vaccine. I. A study of the safety of vaccinal strains].
    Likhoded VG; Shuster BIu; Sergeev VV; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jun; 50(6):66-72. PubMed ID: 4780915
    [No Abstract]   [Full Text] [Related]  

  • 59. Salmonella typhi 205aTy, a strain with two attenuating auxotrophic characters, for use in laboratory teaching.
    Brown RF; Stocker BA
    Infect Immun; 1987 Apr; 55(4):892-8. PubMed ID: 3493975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of mutants of Salmonella typhimurium by counter-current distribution in an aqueous two-polymer phase system.
    Stendahl O; Magnusson KE; Tagesson C; Cunningham R; Edebo L
    Infect Immun; 1973 Apr; 7(4):573-7. PubMed ID: 4586859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.